Biomerica (BMRA) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 24.01% |
| Nov 30, 2025 | 14.86% |
| Aug 31, 2025 | 15.21% |
| May 31, 2025 | 18.76% |
| Feb 28, 2025 | -5.04% |
| Nov 30, 2024 | -22.75% |
| Aug 31, 2024 | -28.41% |
| May 31, 2024 | -43.44% |
| Feb 29, 2024 | -42.10% |
| Nov 30, 2023 | -44.69% |
| Aug 31, 2023 | -68.75% |
| May 31, 2023 | -51.82% |
| Feb 28, 2023 | -41.15% |
| Nov 30, 2022 | -44.02% |
| Aug 31, 2022 | -41.24% |
| May 31, 2022 | -37.01% |
| Feb 28, 2022 | -45.85% |
| Nov 30, 2021 | -34.91% |
| Aug 31, 2021 | -22.42% |
| May 31, 2021 | -17.33% |
| Feb 28, 2021 | -43.74% |
| Nov 30, 2020 | -54.63% |
| Aug 31, 2020 | -50.79% |
| May 31, 2020 | -51.34% |
| Feb 29, 2020 | -15.34% |
| Nov 30, 2019 | 12.66% |
| Aug 31, 2019 | 13.28% |
| May 31, 2019 | 14.57% |
| Feb 28, 2019 | 11.23% |
| Nov 30, 2018 | 7.35% |
| Aug 31, 2018 | 22.48% |
| May 31, 2018 | 13.37% |
| Feb 28, 2018 | 23.77% |
| Nov 30, 2017 | 7.30% |
| Aug 31, 2017 | 3.61% |
| May 31, 2017 | -2.61% |
| Feb 28, 2017 | -11.40% |
| Nov 30, 2016 | -10.77% |
| Aug 31, 2016 | -12.23% |
| May 31, 2016 | -13.81% |
| Feb 29, 2016 | 1.01% |
| Nov 30, 2015 | 7.93% |
| Aug 31, 2015 | -1.90% |